Pharmacodermic reaction in a Yorkshire Terrier after administration of metronidazole with amoxillin-clavulanate potassium

Abstract

The administration of drugs for the treatment, prevention, and diagnosis of diseases is widely used in veterinary medicine; however, this practice may cause unwanted reactions in some cases, even when used at the recommended doses, routes of administration, and intervals. Regarding the clinical manifestations, these can involve any organ or system, but the skin is the most frequently affected organ, classifying it as a pharmacoderma. Pharmacoderma, although considered a rare condition in dogs, is extremely important in the veterinary routine, given its severity and difficult diagnosis due to the non-specificity of clinical signs. The present case report aimed to describe the case of an eleven-year-old female Yorkshire Terrier. The animal was treated with amoxicillin + potassium clavulanate subcutaneously at a dose of 20mg/mL every 8 hours and intravenous metronidazole at a dose of 15mg/mL, every 12 hours. After the treatment, it presented necrotic skin lesions on the back, showing clinical improvement and regression of lesions after immediate suspension of medication. Thus, the pharmacoderma of toxic epidermal necrolysis type was defined as the presumptive diagnosis. In this way, Therefore, the present work aims to disseminate information about pharmacodermia, seeking to guide the therapeutic conduct of patients with this condition since it is a disease that is rarely reported in veterinary medicine.